This is a new tamper proof drug which means if it is crushed it looses it affect, but of course imagepeople can still swallow the pills.  Purdue will have to conducted follow up studies on rates of abuse, addiction and death as that’s a standard anymore for any Opioid drugs.  BD

Washington • The Food and Drug Administration has approved a new combination pain pill from the maker of OxyContin that is designed to discourage abuse by painkiller addicts.

Purdue Pharma’s new drug Targiniq ER is an extended release tablet that combines oxycodone — the active ingredient in OxyContin — with the drug naloxone. FDA regulators approved the drug for daily, round-the-clock pain that does not respond to other medications.

Stamford, Connecticut-based Purdue has often been cited by public health advocates as a key contributor to the overprescribing of opioids. In 2007, Purdue Pharma and three of its executives paid $634 million and pleaded guilty to charges of misleading the public about the safety and addictiveness of OxyContin.


Post a Comment

Google Analytics Alternative